🔗 Share this article

Chancellor Rachel Reeves has announced she is preparing "specific steps to deal with cost of living challenges" in the upcoming financial statement.

During an interview with media outlets, she emphasized that reducing price rises is a collective duty of both the government and the central bank.

The UK's inflation rate is forecast to be the highest among the Group of Seven industrialized countries this calendar year and the following year.

Possible Utility Cost Interventions

Reports indicate the government could intervene to bring down energy bills, for instance by slashing the present 5% level of VAT charged on energy supplies.

Another approach is to lower some of the policy costs presently added to household expenses.

Budgetary Constraints and Analyst Expectations

The administration will receive the latest draft from the official forecaster, the Office for Budget Responsibility, on Monday, which will reveal how much room there is for these measures.

The consensus from most experts is that the Chancellor will have to announce higher taxes or expenditure reductions in order to adhere to her declared fiscal targets.

Earlier on Thursday, analysis indicated there was a £22 billion deficit for the chancellor to fill, which is at the more modest range of expectations.

"There's a joint job between the central bank and the government to further reduce some of the sources of price increases," the Chancellor stated to the BBC in the US capital, at the annual meetings of the International Monetary Fund and World Bank.

Revenue Commitments and International Concerns

While a great deal of the focus has been on probable tax rises, the Treasury chief said the latest data from the fiscal watchdog had not changed her commitment to manifesto promises not to increase rates on income tax, sales tax or social security contributions.

She attributed an "unpredictable world" with rising geopolitical and trade concerns for the fiscal revenue measures, probably to be targeted on those "with the broadest shoulders."

International Trade Tensions

Commenting on worries about the United Kingdom's commercial links with the Asian nation she said: "The UK's security interests invariably come first."

Recent declaration by Chinese authorities to strengthen trade restrictions on critical minerals and other resources that are crucial for advanced tech production led US President the US President to suggest an further 100% import tax on imports from China, increasing the prospect of an all-out commercial conflict between the two economic giants.

The American finance chief labeled the Chinese move "commercial pressure" and "a global supply chain control attempt."

Questioned on considering the US offer to participate in its dispute with China, the Chancellor said she was "extremely troubled" by Chinese measures and encouraged the Chinese government "not to put up barriers and restrict access."

She said the action was "harmful for the world economy and generates further obstacles."

"In my view there are fields where we should address China, but there are also valuable opportunities to sell into China's economy, including financial services and other areas of the economy. We've got to maintain that equilibrium right."

The chancellor also confirmed she was cooperating with other major economies "on our own essential resources approach, so that we are reduced dependence."

Health Service Drug Pricing and Funding

Reeves also acknowledged that the price the NHS pays for pharmaceuticals could rise as a consequence of current negotiations with the US government and its drugs companies, in return for reduced taxes and capital.

Some of the biggest global drug companies have said recently that they are either halting or scrapping investments in the United Kingdom, with several blaming the insufficient payments they are getting.

Last month, the government science advisor said the cost the health service spends on drugs would need to increase to stop businesses and pharmaceutical investment departing from the United Kingdom.

The Chancellor told the BBC: "It has been observed due to the payment system, that clinical trials, new drugs have not been provided in the UK in the way that they are in other EU nations."

"Our aim is to ensure that people receiving care from the National Health Service are able to obtain the top life-saving medicines in the world. And so we are reviewing all of that, and... looking to attract additional funding into Britain."